Eli Lilly and Company plans to acquire Merida Biosciences for up to $2.8 billion in cash.
2 reports, 1 independent
Updated Sep 2
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Eli Lilly and Company plans to acquire Merida Biosciences for up to $2.8 billion in cash.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Eli Lilly and Company
American pharmaceutical company
Related events
- Eli Lilly is acquiring Merida Biosciences for up to $2.875 billion in cash, while oil prices rise above $85/$90 amid tensions, coinciding with a hawkish Fed speech from Jackson Hole.
- Soutrik Banerjee is currently employed as a consultant at Eli Lilly and Company.
- Eli Lilly and Company entered a strategic partnership with Twist Bioscience Corporation regarding data provision and services.
- Eli Lilly captured market share from Novo Nordisk in the weight loss drug sector.
- A senior research scientist from Eli Lilly and Company is presenting abstracts at the AAIC conference in London.